REGENXBIO Inc. (RGNX)
NASDAQ·Healthcare·Biotechnology
$8.53
-0.12%
Mkt Cap $440.98M
Analyst Ratings
Buy
9
Hold
1
Sell
0
Price Target (25 analysts)
$19.14
Range $12.00 – $32.00
Implied Upside
+124.4%
Consensus $19.14 vs current $8.53
NASDAQ·Healthcare·Biotechnology
$8.53
-0.12%
Mkt Cap $440.98M
Buy
9
Hold
1
Sell
0
Price Target (25 analysts)
$19.14
Range $12.00 – $32.00
+124.4%
Consensus $19.14 vs current $8.53